R&D | May 25, 2026
AbbVie signals major oncology momentum at ASCO
With standout ADC and t-cell engager response data across hard-to-treat cancers
With standout ADC and t-cell engager response data across hard-to-treat cancers
Highlights strong Vibegron results in older men & real-world prostate cancer insights
New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain
The approval was granted by Agenzia Italiana del Farmaco
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices
BMS is moving beyond conversational AI into what it describes as “agentic” systems
All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
Initiative focuses on early diagnosis, gut health awareness and long-term gluten-free care for children with celiac disease
Subscribe To Our Newsletter & Stay Updated
